BioSpace News Archive

Deals

Mirati Therapeutics Announces Pricing Of Public Offering Of 2,750,000 Common Stock

Mirati Therapeutics, Inc. announced the pricing of an underwritten public offering of 2,750,000 shares of its common stock at a price to the public of $38.85 per share.

June 7, 2018
·
5 min read
Pharm Country

DarioHealth Provides Update on Recently Launched iPhone 7, 8 and X Smart Glucose Meter in the U.S. Following FDA Clearance

DarioHealth Reveals First Indication of U.S. Market Opportunity

June 7, 2018
·
4 min read
Pharm Country

Taiho Oncology Eliminates Co-Pays for Many of the Patients Treated with LONSURF® (trifluridine and tipiracil)

Taiho’s Patient Assistance Programs Commit to Addressing Patient Burden through New Program Enhancements

June 7, 2018
·
11 min read
BioMidwest

Rockwell Medical Provides Update on Commercial Strategy for Triferic

Company to Move Forward with Commercialization of Triferic

June 7, 2018
·
6 min read
Deals

BrainStorm Announces Exercise of Warrants Resulting in Cash Proceeds of ~$12.3 Million at $5 Share

BrainStorm Cell Therapeutics Inc. announced it has entered into a Warrant Exercise Agreement with certain holders of warrants issued in the January 8, 2015 private placement.

June 7, 2018
·
4 min read
Biotech Bay

SutroVax Announces $85M Series C Financing led by TPG Growth

Provides growth capital to advance pneumococcal vaccine to clinic and beyond

June 7, 2018
·
8 min read
Pharm Country

Henry Schein Medical Launches Its New EasyOne Air Spirometer

New Portable Spirometry Solution Uses TrueFlow Ultrasound Technology for Precise and Reliable Diagnosis

June 7, 2018
·
3 min read
Genetown

Florida Hospital First in Sunshine State to Adopt NeuroLogica’s BodyTom® Elite

NeuroLogica announced that Florida Hospital in Orlando, Florida, added the BodyTom® Elite, the newly upgraded, portable, 32-slice computed tomography scanner, to their brachytherapy suite.

June 7, 2018
·
4 min read
Business

Generation Bio Appoints Jeff Jonas M.D. to its Board of Directors

Generation Bio today announced the appointment of Jeff Jonas, M.D., chief executive officer of Sage Therapeutics, to its Board of Directors.

June 7, 2018
·
2 min read
Drug Development

Atreca to Present Immuno-Oncology Research Findings at 2018 World Preclinical Congress

Atreca, Inc. announced today that Norman Michael Greenberg, Ph.D., Senior Vice President and Chief Scientific Officer at Atreca, will deliver a presentation during the 2018 World Preclinical Congress (WPC) Annual Meeting.

June 7, 2018
·
2 min read